An EU-funded chemist has won a share of the Nobel Prize in Chemistry for a technique that enables researchers to peer into the nanoworld of individual molecules.
Professor Stefan W. Hell, who has received EU funding multiple times, won the prize alongside US researchers Professor William E. Moerner and Dr Eric Betzig. The trio are credited with creating microscopes that can see at a greater resolution than half the wavelength of light.
That’s significant because Ernst Abbe, a famous microscopist in the 1800s, had used mathematics to show that scientists would never be able to view organisms with a microscope which were smaller than that.
‘So much physics happened in the twentieth century that it was impossible that there was no phenomenon that wouldn’t allow you to overcome the physical diffraction barrier that was coined in 1873 or so,’ Prof. Hell said in an audio interview posted on the Nobel Prize website. ‘I felt that there had to be something.’
In 1994 as a post-doctoral researcher at the University of Turku, in Finland, he published a theoretical article outlining how he could use fluorescence techniques to build a kind of flashlight which would generate an image of far greater resolution than previously achieved.
‘It was impossible that there was no phenomenon that wouldn’t allow you to overcome the physical diffraction barrier.’
Professor Stefan W. Hell
He received funding from Marie Skłodowska-Curie Actions (MSCA) to work on so-called fluorescence microscopy and then was invited to the Max Planck Institute for Biophysical Chemistry in Germany. Here he managed to develop one of these microscopes, and in the year 2000 he imaged an E.coli bacterium at a never-before-seen resolution.
Having benefitted from the MSCA grant himself, Professor Hell later coordinated three MSCA individual fellowships. He and his fellow researchers at the Max Planck Institute for Biophysical Chemistry in Göttingen also participated in collaborative projects funded by the EU, including the FLUODIAMON project which looked at using fluorescence microscopy to detect cancer. This year, three Nobel Prizes – for Physiology/Medicine, Physics and Chemistry – have all had links to the EU’s MSCA programme.
European Commissioner Androulla Vassiliou, responsible for the MCSA scheme and European Commissioner for Research, Innovation and Science Máire Geoghegan-Quinn said in a joint statement: ‘Outstanding researchers like Stefan W. Hell are an excellent example of what European research mobility can achieve.’
Prof. Moerner and Dr Betzig, developed a separate method called single-molecule microscopy.
These discoveries mean that researchers can now track proteins involved in diseases like Parkinson’s and Alzheimer’s, and follow individual proteins in fertilized eggs as these divide into embryos.
More than six months into the coronavirus crisis, data show that not just age, but also biological sex plays a pivotal role in the manifestation and response to Covid-19, with more men dying from acute infections versus women in the short term. This discrepancy has shined a spotlight on a key theme that has gained traction in recent years: is enough being done to account for sex and gender in disease and medicine? Not enough, says Dr Sabine Oertelt-Prigione, the chair of sex and gender-sensitive medicine at Radboud University in the Netherlands and a member of the European Commission’s expert group on gendered innovations.
Infants born early, before 37 weeks of pregnancy, have a higher risk of dying in childhood and often suffer from lifelong health problems. But two novel devices could help cut this risk – one by improving how risk of an early birth is assessed and the other by offering personalised nutritional advice for premature babies.
Eavesdropping on the shudders and groans echoing deep inside alien worlds like Mars and the moon is revealing what lies far beneath their surfaces and could teach us more about how our own planet formed.
Earth is not the only place in our solar system that shakes with seismic activity.
Dr Sabine Oertelt-Prigione on a ‘moment of awakening’ for medical research.
Dr Kate Rychert studies ocean plate structures.